US Stock MarketDetailed Quotes

CYCN Cyclerion Therapeutics

Watchlist

2.8500
-0.00010.00%

Close May 17 16:00 ET

7.72MMarket Cap8.64P/E (TTM)

Cyclerion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-20.55%5.7M

-43.42%7.57M

-55.36%9.11M

-81.40%5.64M

-82.57%7.17M

-75.20%13.38M

-67.35%20.41M

-56.92%30.32M

-Cash and cash equivalents

-20.55%5.7M

-43.42%7.57M

-55.36%9.11M

-81.40%5.64M

-82.57%7.17M

-75.20%13.38M

-67.35%20.41M

-56.92%30.32M

Receivables

----

--0

-57.71%96K

-4.00%96K

43.67%227K

--227K

-Accounts receivable

----

--0

-57.71%96K

-4.00%96K

43.67%227K

--227K

Prepaid assets

-45.68%308K

-45.09%442K

35.45%726K

61.36%1.04M

-43.69%567K

-13.25%805K

-4.63%536K

-15.54%647K

Other current assets

-98.01%10K

-97.95%11K

-93.85%30K

-11.20%428K

5.45%503K

14.74%537K

6.32%488K

-73.70%482K

Total current assets

-27.85%6.01M

-45.86%8.02M

-54.45%9.86M

-77.55%7.11M

-80.54%8.34M

-73.28%14.82M

-65.99%21.66M

-56.60%31.68M

Non current assets

Net PPE

--0

-14.12%1.13M

-14.71%1.17M

-16.97%1.22M

-19.03%1.26M

756.21%1.31M

-Gross PPE

-89.24%126K

-96.29%126K

--0

-7.89%3.29M

-67.66%1.17M

-7.31%3.4M

-4.98%3.53M

58.33%3.58M

-Accumulated depreciation

---126K

94.22%-126K

----

4.28%-2.17M

----

0.86%-2.18M

-5.20%-2.27M

-7.60%-2.27M

Investments and advances

--5.35M

----

--0

----

Other non current assets

----

-16.41%1.86M

-15.80%1.95M

-15.21%2.04M

-14.65%2.13M

-14.13%2.22M

Total non current assets

71.42%5.35M

64.16%5.35M

57.49%5.35M

-15.56%2.98M

-15.40%3.12M

-15.88%3.26M

-16.33%3.4M

28.84%3.53M

Total assets

-0.80%11.36M

-26.02%13.37M

-39.27%15.21M

-71.33%10.1M

-75.38%11.46M

-69.53%18.08M

-63.02%25.05M

-53.50%35.21M

Liabilities

Current liabilities

Payables

-81.12%741K

-59.66%1.2M

-50.52%814K

-32.63%1.86M

55.82%3.93M

62.47%2.97M

40.12%1.65M

99.64%2.77M

-accounts payable

-81.12%741K

-59.66%1.2M

-50.52%814K

-32.63%1.86M

55.82%3.93M

62.47%2.97M

40.12%1.65M

99.64%2.77M

Current accrued expenses

-80.59%539K

-76.58%786K

-80.44%1.05M

-57.79%2.38M

-51.31%2.78M

-52.17%3.36M

22.65%5.38M

52.33%5.63M

Other current liabilities

15.00%161K

50.00%102K

-0.63%158K

-10.26%175K

-63.73%140K

-87.07%68K

-80.91%159K

-12.16%195K

Current liabilities

-80.87%1.44M

-72.65%2.09M

-72.55%2.34M

-49.79%4.95M

-20.65%7.53M

-31.20%7.63M

-24.89%8.53M

-6.26%9.85M

Non current liabilities

Total non current liabilities

--0

Total liabilities

-80.87%1.44M

-72.65%2.09M

-72.55%2.34M

-49.79%4.95M

-20.65%7.53M

-31.20%7.63M

-24.89%8.53M

-6.26%9.85M

Shareholders'equity

Share capital

--0

-common stock

--0

-Preferred stock

--0

----

--0

----

Retained earnings

0.06%-265.96M

-2.03%-264.42M

-4.28%-262.72M

-11.95%-270.29M

-16.69%-266.11M

-20.49%-259.15M

-23.32%-251.94M

-25.09%-241.44M

Paid-in capital

2.16%275.9M

2.26%275.72M

2.65%275.61M

3.23%275.46M

1.86%270.05M

2.39%269.63M

2.98%268.49M

3.32%266.83M

Gains losses not affecting retained earnings

15.79%-16K

40.00%-12K

35.71%-18K

36.00%-16K

20.83%-19K

13.04%-20K

-7.69%-28K

3.85%-25K

Total stockholders'equity

152.82%9.92M

8.00%11.29M

-22.10%12.87M

-79.69%5.15M

-89.40%3.93M

-78.34%10.45M

-70.70%16.52M

-61.12%25.36M

Total equity

152.82%9.92M

8.00%11.29M

-22.10%12.87M

-79.69%5.15M

-89.40%3.93M

-78.34%10.45M

-70.70%16.52M

-61.12%25.36M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-20.55%5.7M	-43.42%7.57M	-43.42%7.57M	-55.36%9.11M	-81.40%5.64M	-82.57%7.17M	-75.20%13.38M	-75.20%13.38M	-67.35%20.41M	-56.92%30.32M
-Cash and cash equivalents	-20.55%5.7M	-43.42%7.57M	-43.42%7.57M	-55.36%9.11M	-81.40%5.64M	-82.57%7.17M	-75.20%13.38M	-75.20%13.38M	-67.35%20.41M	-56.92%30.32M
Receivables	----	--0	--0	--0	--0	-57.71%96K	-4.00%96K	-4.00%96K	43.67%227K	--227K
-Accounts receivable	----	--0	--0	--0	--0	-57.71%96K	-4.00%96K	-4.00%96K	43.67%227K	--227K
Prepaid assets	-45.68%308K	-45.09%442K	-45.09%442K	35.45%726K	61.36%1.04M	-43.69%567K	-13.25%805K	-13.25%805K	-4.63%536K	-15.54%647K
Other current assets	-98.01%10K	-97.95%11K	-97.95%11K	-93.85%30K	-11.20%428K	5.45%503K	14.74%537K	14.74%537K	6.32%488K	-73.70%482K
Total current assets	-27.85%6.01M	-45.86%8.02M	-45.86%8.02M	-54.45%9.86M	-77.55%7.11M	-80.54%8.34M	-73.28%14.82M	-73.28%14.82M	-65.99%21.66M	-56.60%31.68M
Non current assets
Net PPE	--0	--0	--0	--0	-14.12%1.13M	-14.71%1.17M	-16.97%1.22M	-16.97%1.22M	-19.03%1.26M	756.21%1.31M
-Gross PPE	-89.24%126K	-96.29%126K	-96.29%126K	--0	-7.89%3.29M	-67.66%1.17M	-7.31%3.4M	-7.31%3.4M	-4.98%3.53M	58.33%3.58M
-Accumulated depreciation	---126K	94.22%-126K	94.22%-126K	----	4.28%-2.17M	----	0.86%-2.18M	0.86%-2.18M	-5.20%-2.27M	-7.60%-2.27M
Investments and advances	--5.35M	--5.35M	--5.35M	--5.35M	----	----	--0	--0	----	----
Other non current assets	----	----	----	----	-16.41%1.86M	-15.80%1.95M	-15.21%2.04M	-15.21%2.04M	-14.65%2.13M	-14.13%2.22M
Total non current assets	71.42%5.35M	64.16%5.35M	64.16%5.35M	57.49%5.35M	-15.56%2.98M	-15.40%3.12M	-15.88%3.26M	-15.88%3.26M	-16.33%3.4M	28.84%3.53M
Total assets	-0.80%11.36M	-26.02%13.37M	-26.02%13.37M	-39.27%15.21M	-71.33%10.1M	-75.38%11.46M	-69.53%18.08M	-69.53%18.08M	-63.02%25.05M	-53.50%35.21M
Liabilities
Current liabilities
Payables	-81.12%741K	-59.66%1.2M	-59.66%1.2M	-50.52%814K	-32.63%1.86M	55.82%3.93M	62.47%2.97M	62.47%2.97M	40.12%1.65M	99.64%2.77M
-accounts payable	-81.12%741K	-59.66%1.2M	-59.66%1.2M	-50.52%814K	-32.63%1.86M	55.82%3.93M	62.47%2.97M	62.47%2.97M	40.12%1.65M	99.64%2.77M
Current accrued expenses	-80.59%539K	-76.58%786K	-76.58%786K	-80.44%1.05M	-57.79%2.38M	-51.31%2.78M	-52.17%3.36M	-52.17%3.36M	22.65%5.38M	52.33%5.63M
Other current liabilities	15.00%161K	50.00%102K	50.00%102K	-0.63%158K	-10.26%175K	-63.73%140K	-87.07%68K	-87.07%68K	-80.91%159K	-12.16%195K
Current liabilities	-80.87%1.44M	-72.65%2.09M	-72.65%2.09M	-72.55%2.34M	-49.79%4.95M	-20.65%7.53M	-31.20%7.63M	-31.20%7.63M	-24.89%8.53M	-6.26%9.85M
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	-80.87%1.44M	-72.65%2.09M	-72.65%2.09M	-72.55%2.34M	-49.79%4.95M	-20.65%7.53M	-31.20%7.63M	-31.20%7.63M	-24.89%8.53M	-6.26%9.85M
Shareholders'equity
Share capital	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-common stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-Preferred stock	--0	--0	--0	--0	--0	----	--0	--0	----	----
Retained earnings	0.06%-265.96M	-2.03%-264.42M	-2.03%-264.42M	-4.28%-262.72M	-11.95%-270.29M	-16.69%-266.11M	-20.49%-259.15M	-20.49%-259.15M	-23.32%-251.94M	-25.09%-241.44M
Paid-in capital	2.16%275.9M	2.26%275.72M	2.26%275.72M	2.65%275.61M	3.23%275.46M	1.86%270.05M	2.39%269.63M	2.39%269.63M	2.98%268.49M	3.32%266.83M
Gains losses not affecting retained earnings	15.79%-16K	40.00%-12K	40.00%-12K	35.71%-18K	36.00%-16K	20.83%-19K	13.04%-20K	13.04%-20K	-7.69%-28K	3.85%-25K
Total stockholders'equity	152.82%9.92M	8.00%11.29M	8.00%11.29M	-22.10%12.87M	-79.69%5.15M	-89.40%3.93M	-78.34%10.45M	-78.34%10.45M	-70.70%16.52M	-61.12%25.36M
Total equity	152.82%9.92M	8.00%11.29M	8.00%11.29M	-22.10%12.87M	-79.69%5.15M	-89.40%3.93M	-78.34%10.45M	-78.34%10.45M	-70.70%16.52M	-61.12%25.36M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall